Heidelberg Pharma shortlisted for World Award Munich, Germany, 20 September 2017 - WILEX AG (ISIN DE000A11QVV0 / WL6 / FSE) today announced that its subsidiary, Heidelberg Pharma Research GmbH, Ladenburg, Germany, will present at the 8 Annual World Summit taking place on 20-22 September in San Diego, CA, USA. This annual summit is expected to draw record attendance from over 650 companies including large and small pharma, biotech, academia as well as CROs, CMOs and industry suppliers that cover every element of Drug Conjugate () development. The World Summit organizes cutting-edge science and transformative insights. Further information can be found at: http://worldadc-usa.com. Details of...
|
